W. Vanderkloot et al., CALCITONIN-GENE-RELATED PEPTIDE ACTS PRESYNAPTICALLY TO INCREASE QUANTAL SIZE AND OUTPUT AT FROG NEUROMUSCULAR-JUNCTIONS, Journal of physiology, 507(3), 1998, pp. 689-695
1. Calcitonin gene-related peptide (CGRP) is found in dense-cored vesi
cles in the motor nerve terminal. 2. Exogenous CGRP increased the size
of the quanta. The increase in size reached a maximum after about 40
min. The lowest effective concentration of human CGRP (hCGRP) was 0.8
nM. The action of hCGRP was antagonized by (-)-vesamicol, a drug that
blocks active acetylcholine (ACh) uptake into synaptic vesicles, so it
appears that hCGRP increases size by adding more ACh to the quanta. T
he action of hCGRP was antagonized by drugs that block the activation
of protein kinase A (PKA). (In other preparations CGRP also activates
PKA.) 3. The hCGRP effect was not blocked by fragment 8-37, an antagon
ist of one class of CGRP receptor. 4. hCGRP increases evoked quantal o
utput and miniature endplate potential (MEPP) frequency, again by acti
vating PKA. 5. CGRP release was measured by radioimmunoassay. Release
was increased by depolarization with elevated K+, but the amounts rele
ased appear to be below those needed to affect quantal size or output.
Moreover, although elevated K+ can increase quantal size it acts by a
pathway that does not involve PKA. We suggest that the most likely ta
rget of endogenously released CGRP is the regulation of circulation of
the muscle.